Diabetes: Insulet inks deal with J&J’s LifesScan for next-gen OmniPod

February 16, 2012 By MassDevice staff

Updated: February 17, 2012 10 a.m.

The next generation of Insulet’s (NSDQ:PODD) OmniPod insulin pump, which is awaiting 510(k) clearance from the FDA, will be compatible with the LifeScan blood glucose monitoring technology made by Johnson & Johnson (NYSE:JNJ).

The 2 companies inked a deal for LifeScan’s OneTouch technology to be incorporated into a new personal diabetes manager that patients use to control the OmniPod. Insulet’s chief commercial officer, Peter Devlin, told MassDevice.com that the company is targeting a mid-2013 commercial release.

"It’s essentially a new device that will require 510(k) clearance," Devlin explained. "By having the BGM integrated in the PDM, it simply makes that aspect of controlling your diabetes a bit easier."

Insulet already has a deal with Abbott (NYSE:ABT) and its FreeStyle BGM, but that pact is set to expire in 2013, he said. The OneTouch agreement with LifeScan runs through 2017 and has a trigger that would make it exclusive at Insulet’s discretion, according to a press release.

The next-generation OmniPod, the Eros, is awaiting a decision from the FDA’s Center for Devices & Radiological Health on its bid for clearance for the U.S. market. Although Devlin said Insulet "is not in the business of projecting when the FDA is going to approve anything," the company is hoping for a mid-2012 launch for that device as well.*

"The Eros system will be compatible with both the Abbott strip, because it is a platform we intend to launch this year," he said. "When the OneTouch-integrated device is available, we have the option to either maintain 2 PDMs with different strips in them, or to select exclusivity with LifeScan and just sell that on a go-forward basis. That’s a decision we’ll make as we get closer to 2013."

Insulet shopped around for a deal before settling on LifeScan, largely for the scale of its market access, Devlin added.

"There were a number of BGM companies that we spoke to that expressed interest in being a partner, and ultimately when we looked at LifeScan as a potetial suitor, the big value that it brings to us is simply access to a larger portion of people. LifeScan is the blood glucose monitoring market leader in the U.S.," he noted.

David Kliff, publisher of the Diabetic Investor,, an internet based informational source covering the business of diabetes, wrote that the deal could position Insulet and J&J for a run at Medtronic (NYSE:MDT), which has a hold on about 70% of the U.S. insulin pump market.

"Medtronic owns the market and no one, so far, has figured out a way to steal away share and give them a run for their money," Kliff wrote. "The question today is really no different than it was 5 or even 10 years ago: ‘Can anyone knock Medtronic off its pedestal?’"

Devlin said Insulin continues to increase its market share due to a confluence of several factors, not just its latest deal.

"Our next-generation pod continues to position us very well to continue to grow share in the U.S. market," he said. "Having the LifeScan strip incorporated in our device would clearly make our device attractive to a larger group of potential users, bit it’s really a combination of things that continues to position us well for market share growth here in the U.S."

*Correction, February 17, 2012: This article originally stated that the Eros OmniPod is expected to launch in 2013. It is expected mid-2012. Return to the corrected sentence.

Switchback Medical adds ‘sandbox approach’ to device testing
Contract manufacturer Switchback Medical (Maple Grove, Minn.) today announced that it has added a new division. Switchback BioSim Innovations offers functional dynamic biosimulator model development, cell culture services and physician training, according to the company. Biosimulator models use animal and human tissue to create functional models, such as a pumping heart with working valves to… […]
Smith College team wins ventilator design challenge
A team of Smith College engineering alumnae, staff and faculty has won the CoVent-19 Challenge to design a rapidly deployable ventilator to address shortages caused by the COVID-19 pandemic, particularly in developing countries. A dozen anesthesiology resident physicians from Massachusetts General Hospital kicked off the public challenge April 1, attracting 200 entries. The 30-person team… […]
FDA gives certain device makers more time to add UDIs
The FDA said today that it will grant manufacturers of Class 1 and unclassified medical devices and certain others more time to add unique device identifiers (UDIs) to their products. These companies will now have until Sept. 24, 2022 to comply with the agency’s UDI rule, including standard date formatting, labeling and Global Unique Device… […]
Eurofins launches 10-minute COVID-19 exposure testing device
Eurofins (Paris:ERF.PA) announced today that it launched its rapid point-of-care testing devices to identify past exposure to COVID-19. The serology-based, finger-prick tests detect antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms, with results coming in just 10 minutes, according to a news release. Get the full story at our sister site,… […]
How is RF technology shaping the future of medtech?
RF technology, including microwaves, isn’t just about wireless communications or military radar these days. Times Microwave Systems experts point out that it is increasingly important when it comes to medtech. Many medical electronics systems such as magnetic resonance imaging (MRI) systems for cancer detection rely on RF/microwave technology. Times Microwave Systems (Wallingford, Conn.) is hosting… […]
Medical device litigation and COVID-19: What you need to know
The COVID-19 pandemic is creating a new set of medical device litigation challenges — but also a chance for an industry reset. One of Greenberg Traurig’s top medtech litigation lawyers shares her insights. Sara Thompson doesn’t take any guff when she tells people that she defends medical device and pharmaceutical companies from lawsuits. “I say,… […]
Mayo Clinic needed to engineer its way through COVID-19: Here’s what they did.
The health system’s medical and engineering staffs had to devise their own solutions for lab gear, PPE and operating room air decontamination. As COVID-19 settles into several regions of the U.S., healthcare systems that once sat on the sidelines likely will find themselves in the same situation as their counterparts in the Northeast did earlier… […]
Xenco Medical launches porous spinal implant
Xenco Medical this week said it launched its Cancellex porous titanium lumbar interbodies. The injection-molded titanium foam spinal implants are designed to be pre-attached to disposable, composite polymer instruments. They feature interconnected porosity throughout each implant and are designed to promote bone apposition and facilitate vascularization Each implant is sterile packaged and comes pre-attached to… […]
Applied Plastics adds VP of sales
Applied Plastics (Norwood, Mass.) — maker of PTFE-coated products for advanced catheter systems — announced today that Michael Brown has joined the company as VP of sales and marketing. Brown will be responsible for global sales and marketing, including Applied Plastics’ new online store, which offers shipment within the U.S. and Europe. The company recently… […]
Heraeus Medical Components opens new Collaboration Hub outside Minneapolis
Heraeus Medical Components recently announced that it has opened a new nearly 67,000-square-foot Collaboration Hub in the Minneapolis-St. Paul medtech cluster. The Collaboration Hub — a completely new location near the Heraeus’ existing Fridley, Minn. facility — is meant to provide the company’s customers with the opportunity to work on-site with Heraeus Medical component R&D… […]
Pantheon Surgical acquires sacroiliac screw system
Pantheon Surgical recently announced its acquisition of the Topaz/Compressive sacroiliac screw system. Pantheon Surgical acquired the technology from Osseus Fusion Systems, which will continue to distribute the Blue Topaz/Compressive system. Financial terms of the deal were undisclosed. “I’m excited about the transfer acquisition of the Blue Topaz/Compressive system into the Pantheon armamentarium. I look forward… […]